FDA warned yourtramadol.com for selling unapproved and misbranded tramadol opioid products to U.S. consumers online.
What happened
FDA reviewed the website www.yourtramadol.com and observed that it offered tramadol marketed as “Ol-Tram Tablets 50mg” under the “Pain Relief” heading. FDA said there is no approved drug application for that product and that its labeling lacks adequate directions for use. FDA also said the site introduces unapproved and misbranded opioid drugs into interstate commerce.
What FDA found
The website offered tramadol tablets without an FDA-approved drug application.
FD&C Act sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]The tramadol labeling did not include adequate directions for safe use by a layperson.
FD&C Act section 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 CFR 201.5Because the drug was not approved in the U.S., it was not exempt from the adequate-directions requirement.
21 CFR 201.115(a)Offering the misbranded drug for sale caused it to be introduced into interstate commerce.
FD&C Act section 301(a) [21 U.S.C. § 331(a)]
What FDA wants
FDA asks the website to stop offering any unapproved and misbranded drugs for sale to U.S. consumers and to notify FDA in writing within 15 working days of steps taken to address the violations and prevent recurrence.
Who should pay attention
- online pharmacies and drug e-commerce sites
- telehealth or prescribing platforms that link to online drug sellers
- consumers who buy prescription drugs online
This is a summary. Read the original letter on fda.gov.